Home › Ewing Sarcoma › Oregon
Ewing Sarcoma clinical trials in Oregon
3 studies for Ewing Sarcoma are looking for participants at sites in Oregon.
Cities in Oregon
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Oregon Health and Science University ( Site 1004), Portland
RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Oct 30, 2026 · NCT06395103Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Randall Children's Hospital, Portland
RecruitingPhase 2
Ages 0 to 50 · All sexes · Updated Oct 6, 2026 · NCT07321912Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Oregon Health & Science University, Portland
RecruitingPhase 1
Ages 12 to 85 · All sexes · Updated Sep 8, 2026 · NCT03715933From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.